EA200200630A1 - Способ получения гидрохлорида эпинастина в виде кристаллической модификации с высокой температурой плавления - Google Patents

Способ получения гидрохлорида эпинастина в виде кристаллической модификации с высокой температурой плавления

Info

Publication number
EA200200630A1
EA200200630A1 EA200200630A EA200200630A EA200200630A1 EA 200200630 A1 EA200200630 A1 EA 200200630A1 EA 200200630 A EA200200630 A EA 200200630A EA 200200630 A EA200200630 A EA 200200630A EA 200200630 A1 EA200200630 A1 EA 200200630A1
Authority
EA
Eurasian Patent Office
Prior art keywords
epinastine
high temperature
crystalline modification
obtaining hydrochloride
hydrochloride
Prior art date
Application number
EA200200630A
Other languages
English (en)
Russian (ru)
Inventor
Рольф Дах
Original Assignee
Бёрингер Ингельхайм Фарма Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бёрингер Ингельхайм Фарма Кг filed Critical Бёрингер Ингельхайм Фарма Кг
Publication of EA200200630A1 publication Critical patent/EA200200630A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EA200200630A 1999-12-03 2000-11-29 Способ получения гидрохлорида эпинастина в виде кристаллической модификации с высокой температурой плавления EA200200630A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19958460A DE19958460A1 (de) 1999-12-03 1999-12-03 Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation
PCT/EP2000/011942 WO2001040229A2 (de) 1999-12-03 2000-11-29 Verfahren zur herstellung von epinastine-hydrochlorid in der hochschmelzenden kristallmodifikation

Publications (1)

Publication Number Publication Date
EA200200630A1 true EA200200630A1 (ru) 2002-12-26

Family

ID=7931396

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200630A EA200200630A1 (ru) 1999-12-03 2000-11-29 Способ получения гидрохлорида эпинастина в виде кристаллической модификации с высокой температурой плавления

Country Status (23)

Country Link
US (1) US6403790B1 (cg-RX-API-DMAC10.html)
EP (1) EP1237892B1 (cg-RX-API-DMAC10.html)
JP (1) JP4789383B2 (cg-RX-API-DMAC10.html)
KR (1) KR100737191B1 (cg-RX-API-DMAC10.html)
CN (1) CN1402728A (cg-RX-API-DMAC10.html)
AR (1) AR026678A1 (cg-RX-API-DMAC10.html)
AT (1) ATE238306T1 (cg-RX-API-DMAC10.html)
AU (1) AU2163501A (cg-RX-API-DMAC10.html)
BR (1) BR0016052A (cg-RX-API-DMAC10.html)
CA (1) CA2389170C (cg-RX-API-DMAC10.html)
CO (1) CO5251470A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ20021843A3 (cg-RX-API-DMAC10.html)
DE (2) DE19958460A1 (cg-RX-API-DMAC10.html)
DK (1) DK1237892T3 (cg-RX-API-DMAC10.html)
EA (1) EA200200630A1 (cg-RX-API-DMAC10.html)
ES (1) ES2198368T3 (cg-RX-API-DMAC10.html)
HU (1) HUP0203501A2 (cg-RX-API-DMAC10.html)
IL (1) IL149711A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA02005330A (cg-RX-API-DMAC10.html)
PL (1) PL355628A1 (cg-RX-API-DMAC10.html)
PT (1) PT1237892E (cg-RX-API-DMAC10.html)
UY (1) UY26461A1 (cg-RX-API-DMAC10.html)
WO (1) WO2001040229A2 (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
JP4298212B2 (ja) * 2002-03-29 2009-07-15 大日本印刷株式会社 塩酸エピナスチン高融点型結晶の製造法
BR0313175A (pt) * 2002-08-02 2005-06-14 Boehringer Ingelheim Int Formulações farmacêuticas compreendendo combinações de epinastina, pseudoefedrina e metilefedrina
KR101386530B1 (ko) 2006-12-29 2014-04-18 케이피엑스 라이프사이언스 주식회사 순도 및 수율이 향상된3-아미노-9,13b디하이드로-1H-디벤즈-[c,f]이미다조[1,5-a]-아제핀 염산염의 제조방법
CN104098575B (zh) * 2013-04-15 2016-06-01 四川科瑞德凯华制药有限公司 一种盐酸依匹斯汀晶型及其制备方法和用途
CN115448927A (zh) * 2022-10-20 2022-12-09 重庆瑞泊莱医药科技有限公司 一种氢溴酸依匹斯汀晶型ii及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3008944A1 (de) * 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Dibenzimidazoazepine, ihre herstellung und verwendung
DE4102148A1 (de) * 1991-01-25 1992-07-30 Boehringer Ingelheim Kg Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid
JP3726291B2 (ja) * 1993-07-05 2005-12-14 三菱ウェルファーマ株式会社 安定な結晶構造を有するベンゾオキサジン化合物およびその製造法
JPH083160A (ja) * 1994-06-22 1996-01-09 Nippon Kayaku Co Ltd 6−(1−h−イミダゾール−1−イル)−7−ニトロ−2,3−(1h,4h)−キノキサリンジオン塩酸塩又は硫酸塩の分離精製法
JP3755908B2 (ja) * 1994-08-17 2006-03-15 塩野義製薬株式会社 セファロスポリン化合物の晶析法
JPH0948765A (ja) * 1995-08-04 1997-02-18 Toyama Chem Co Ltd 安定な結晶構造を有するトリアゾール誘導体およびその製造法
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne

Also Published As

Publication number Publication date
CO5251470A1 (es) 2003-02-28
WO2001040229A2 (de) 2001-06-07
CZ20021843A3 (cs) 2002-08-14
JP4789383B2 (ja) 2011-10-12
ES2198368T3 (es) 2004-02-01
DE19958460A1 (de) 2001-06-07
JP2003515536A (ja) 2003-05-07
UY26461A1 (es) 2001-07-31
MXPA02005330A (es) 2003-01-28
EP1237892B1 (de) 2003-04-23
PL355628A1 (en) 2004-05-04
PT1237892E (pt) 2003-08-29
EP1237892A2 (de) 2002-09-11
CA2389170C (en) 2008-01-08
HUP0203501A2 (hu) 2003-03-28
AR026678A1 (es) 2003-02-19
ATE238306T1 (de) 2003-05-15
CN1402728A (zh) 2003-03-12
KR20020058080A (ko) 2002-07-12
AU2163501A (en) 2001-06-12
DK1237892T3 (da) 2003-08-04
BR0016052A (pt) 2002-07-23
DE50001920D1 (de) 2003-05-28
KR100737191B1 (ko) 2007-07-10
US6403790B1 (en) 2002-06-11
WO2001040229A3 (de) 2001-12-06
IL149711A0 (en) 2002-11-10
CA2389170A1 (en) 2001-06-07

Similar Documents

Publication Publication Date Title
EA199700262A1 (ru) Способ получения 2-метилтиенобензодиазепина и его кристаллические формы
DE69936601D1 (de) Tonerherstellungsverfahren
ID27309A (id) Pasokan daya untuk handphone
DK1065938T3 (da) Fremgangsmåde til fremstilling af et smøremateriale
ID28724A (id) Proses untuk memproduksi sikloalkanon
DE69916904D1 (de) Tonerherstellungsverfahren
ID20274A (id) Proses untuk memproduksi diamina
BR9705745A (pt) Processo para fabricação de uma ferradura bem como ferradura obtida pelo mesmo
DE69927893D1 (de) Tonerherstellungsverfahren
NO20014253L (no) Brönnverktöy med temperaturkompensering
EA200200101A1 (ru) Получение замещенных пиперидин-4-онов
EA199900741A1 (ru) Способ получения эпросартана
NO20011804L (no) En forbedret fremgangsmåte for fremstilling av nye antidiabetiske midler
DK0857206T3 (da) Krystallinsk cellulase samt fremgangsmåde til fremstilling af samme
EA200400211A1 (ru) Лиофилизованная композиция 2-метилтиенобензодиазепина
BR0010292B1 (pt) método para preparar composto sintético livre de dióxido de carbono e pré-reagido para a produção de fórmulas de vidro.
DK79298A (da) Profil for køling af brændstof, en brændstofledning samt en fremgangsmåde til fremstilling heraf
ID21499A (id) Proses untuk memproduksi n-(4-fluorofenil)-n-(1-metiletil)-2-[(5-(trifluorometil)-1,3,4-tiadiazol-2-il)-oksi]-asetamida
EA199900740A1 (ru) Способ получения эпросартана (варианты)
ID27452A (id) Proses untuk membuat urea 1,3-tersubstitusi-4-oksosiklik
ID21435A (id) Proses untuk memproduksi suatu kaprolaktam dengan kemurnian tinggi
FR2782517B1 (fr) Procede de fabrication d'hexafluorophosphate de lithium
FI974489L (fi) Menetelmä mäntyöljyn valmistamiseksi
ID16207A (id) Proses untuk memproduksi 2,6-dimetilnaftalena dengan kemurnian tinggi
UY26461A1 (es) Procedimiento para la preparación de hidrocloruro de epinastina en la modificación cristalina de alto punto de fusión.